AMC Stock Price: AMC Entertainment rises after hours after Q1 earnings beat
Premium|Take advantage of 50% OFF on your first month.
Start your subscription and get access to all our original articles.
You have reached your limit of 5 free articles for this month.
Get Premium without limits for only $9.99 for the first month
Access all our articles, insights, and analysts.
UNLOCK OFFER- NYSE:AMC fell by 9.01% during Monday’s trading session.
- The stock was up nearly 5.0% in after hours trading following its earnings beat.
- Doctor Strange 2 smashes the box office in its first weekend in theaters.
NYSE:AMC started the week off in the red, but a pleasant earnings report after the markets closed signalled an after hours rally for the popular meme stock. On Monday, shares of AMC dropped by 9.01% and closed the trading day at $12.52. The stock recovered in after hours trading, gaining nearly 5.0% at one point following its earnings report after the close. It was another bearish start to the week for the broader markets as all three major indices hit their lowest points of the year so far. The Dow Jones dropped by 653 basis points, while the S&P 500 and NASDAQ sank by 3.2% and 4.29% respectively during the session.
Stay up to speed with hot stocks' news!
AMC reported its Q1 earnings report after the markets closed. The company posted a narrower than expected loss during the quarter, missed on earnings, but beat on revenue estimates. CEO Adam Aron stated that it was the strongest first quarter for AMC in two years, and the string of blockbuster releases this year have been great for business. As of the end of the quarter, AMC reported that it had $1.3 billion in available liquidity.
AMC stock forecast
One of those blockbusters was Marvel’s most recent offering, Doctor Strange in the Multiverse of Madness. The film debuted in US theaters this past weekend and opened to $187 million which is the second best domestic launch of the COVID-19 era. Only two other non-Avenger Marvel movies have reached this figure, so needless to say, Doctor Strange has been a hit after Marvel’s last film, Morbius, was a flop.
Like this article? Help us with some feedback by answering this survey:
- NYSE:AMC fell by 9.01% during Monday’s trading session.
- The stock was up nearly 5.0% in after hours trading following its earnings beat.
- Doctor Strange 2 smashes the box office in its first weekend in theaters.
NYSE:AMC started the week off in the red, but a pleasant earnings report after the markets closed signalled an after hours rally for the popular meme stock. On Monday, shares of AMC dropped by 9.01% and closed the trading day at $12.52. The stock recovered in after hours trading, gaining nearly 5.0% at one point following its earnings report after the close. It was another bearish start to the week for the broader markets as all three major indices hit their lowest points of the year so far. The Dow Jones dropped by 653 basis points, while the S&P 500 and NASDAQ sank by 3.2% and 4.29% respectively during the session.
Stay up to speed with hot stocks' news!
AMC reported its Q1 earnings report after the markets closed. The company posted a narrower than expected loss during the quarter, missed on earnings, but beat on revenue estimates. CEO Adam Aron stated that it was the strongest first quarter for AMC in two years, and the string of blockbuster releases this year have been great for business. As of the end of the quarter, AMC reported that it had $1.3 billion in available liquidity.
AMC stock forecast
One of those blockbusters was Marvel’s most recent offering, Doctor Strange in the Multiverse of Madness. The film debuted in US theaters this past weekend and opened to $187 million which is the second best domestic launch of the COVID-19 era. Only two other non-Avenger Marvel movies have reached this figure, so needless to say, Doctor Strange has been a hit after Marvel’s last film, Morbius, was a flop.
Like this article? Help us with some feedback by answering this survey:
Information on these pages contains forward-looking statements that involve risks and uncertainties. Markets and instruments profiled on this page are for informational purposes only and should not in any way come across as a recommendation to buy or sell in these assets. You should do your own thorough research before making any investment decisions. FXStreet does not in any way guarantee that this information is free from mistakes, errors, or material misstatements. It also does not guarantee that this information is of a timely nature. Investing in Open Markets involves a great deal of risk, including the loss of all or a portion of your investment, as well as emotional distress. All risks, losses and costs associated with investing, including total loss of principal, are your responsibility. The views and opinions expressed in this article are those of the authors and do not necessarily reflect the official policy or position of FXStreet nor its advertisers.